Presbia

Presbia is a publicly traded ophthalmic medical device company based in Irvine, California, specializing in solutions for presbyopia, a condition that affects near vision as people age. Founded in 2007, the company has developed the Presbia Flexivue Microlens™, a miniature, implantable lens designed to correct presbyopia. This lens is inserted into a corneal pocket created by a femtosecond laser, offering a minimally invasive alternative to traditional treatments. The Flexivue Microlens is intended to restore near vision by enhancing the eye's focusing ability without removing the natural lens. Presbia is actively working on obtaining regulatory approvals, including FDA clearance, to expand the availability of this innovative device. The company serves eye care professionals, including ophthalmologists and optometrists, as well as patients seeking surgical solutions for improved near vision. With operations in the United States, Germany, and Ireland, Presbia supports its global commercial and regulatory efforts through a skilled management team experienced in medical device development and clinical research.

• Employees 15
• Founded 2007
• Annual Revenue $10000000
• Total Funding $41666670